Breaking Research News from Breastcancer.org
Comments
-
Breast Density Classification Can Be Unreliable
January 13, 2016
Research shows that breast density classifications can be unreliable -- as many as 22% of women had their breast density change from dense to not dense from mammogram to mammogram. Read more...0 -
Experimental Medicine Offers Same Survival Rates as Taxanes as First Treatment for HER2-Negative, Metastatic Disease
January 22, 2016
Women diagnosed with HER2-negative, metastatic breast cancer had about the same overall survival whether they were treated with S-1 or a taxane. Read more...0 -
Most High-Risk Women Don't Start or Don't Finish Preventive Hormonal Therapy
January 26, 2016
Most women at high risk for breast cancer either refuse to take preventive Evista or tamoxifen or stop taking the medicine early. Read more...0 -
Chemotherapy for Breast Cancer May Increase Risk of Common Infections
January 27, 2016
Women diagnosed with breast cancer who were treated with chemotherapy had lower levels of immune system cells for at least 9 months after chemotherapy ended. Read more...0 -
For Diagnosed Women, It's Never Too Late to Quit Smoking
January 28, 2016
A study found that women who were diagnosed with breast cancer and then quit smoking after diagnosis had a 33% lower risk of dying from breast cancer compared to women who continued to smoke. Read more...0 -
Lipofilling Doesn't Increase Recurrence Risk
February 2, 2016
Women who have lipofilling after reconstruction are no more likely to have a recurrence or be diagnosed with a new cancer than women who never had lipofilling. Read more...0 -
Does Eating Lots of Fiber in High School Really Decrease Breast Cancer Risk?
February 2, 2016
A study suggests that women who ate the most fiber in high school had a lower risk of breast cancer as they aged, compared to women who ate the least amount of fiber in high school. But there are some issues with the research. Read more...0 -
An additional commentary (criticism) about the information put out in the Harvard news release and picked up by other news media
http://www.healthnewsreview.org/2016/02/fiber-and-...
http://www.medpagetoday.com/HematologyOncology/Col...
".....Reporting only of misleadingly high relative risk reductions (e.g. 16% to 24%) when the absolute difference is cancer rates was a tiny 0.2 percentage point....."
0 -
New Type of Lymph Node Surgery May Allow Some Women to Have Fewer Nodes Removed After Chemotherapy Before Surgery
February 6, 2016
A new type of lymph node surgery, called targeted axillary dissection, may allow some women to have fewer lymph nodes removed after neoadjuvant chemotherapy. Read more...0 -
Rates of BRCA Testing Increasing in Younger Diagnosed Women
February 12, 2016
From 2006 to 2013, rates of genetic testing for abnormal BRCA1 and BRCA2 genes increased in women age 40 or younger who were diagnosed with breast cancer, according to a study. Read more...0 -
Side Effects More Severe in Women Taking Hormonal Therapy After Breast Cancer Surgery
February 15, 2016
Compared to diagnosed women who didn't take hormonal therapy after surgery, women who did take hormonal therapy had more severe symptoms such as hot flashes, joint pain, and vaginal dryness. Read more...0 -
Meditation, Music Help Ease Pain, Anxiety, Fatigue During Breast Biopsy
February 15, 2016
Women who listened to a recorded meditation had less pain, anxiety, and fatigue while they were having a breast biopsy. Women who listened to music during the biopsy also had less anxiety and fatigue, but the women who listened to the meditation had the best outcomes. Read more...0 -
Prognostic Score May Help Decide Which Women Get Survival Benefits From Radiation After DCIS Surgery
February 16, 2016
A prognostic score calculated from a set of easy-to-measure risk factors may help figure out which women get survival benefits from radiation therapy after DCIS surgery and which women don't. Read more...0 -
ASCO Issues Guidelines on Using Biomarkers to Make Adjuvant Treatment Decisions for Women Diagnosed With Early-Stage Invasive Disease
February 16, 2016
ASCO has put out new guidelines on using biomarkers to make decisions about treatments after surgery for women diagnosed with early-stage invasive breast cancer. Read more...0 -
Anthracycline Chemotherapy Linked to More Severe Chemo Brain Problems
February 18, 2016
A small retrospective study suggests that a chemotherapy regimen that includes an anthracycline may increase the risk of thinking and memory problems more than regimens that don't include an anthracycline. Read more...0 -
Abraxane Before Surgery More Beneficial Than Taxol for Early-Stage Disease, but Causes More Side Effects
February 22, 2016
Abraxane offers higher pathologic complete response rates than Taxol when used before surgery for early-stage disease. Read more...0 -
Experimental Medicine Neratinib Helps Treat Early-Stage, HER2-Positive Disease
February 23, 2016
When given after surgery, chemotherapy, and Herceptin, neratinib can improve disease-free survival in women diagnosed with early-stage, HER2-positive breast cancer. Read more...0 -
Many Younger Women Don't Think Hormonal Therapy Is Necessary
February 23, 2016
Many young women don't think hormonal therapy is an essential treatment for breast cancer, which may be why they stop the treatment early. Read more...0 -
ASCO Updates Guidelines on Ovarian Suppression After Surgery for Early-Stage, Hormone-Receptor-Positive Disease
February 25, 2016
The American Society of Clinical Oncology has updated its guidelines on using ovarian suppression along with standard hormonal therapy after surgery for premenopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer. Read more...0 -
Benefits of 3-D Mammograms Last Over Time
February 27, 2016
A study looking at 3 years of data on 3-D mammogram screening has found that the benefits of 3-D mammograms, including finding more cancers and reducing call-back rates, last over time. Read more...0 -
Omega-3 Fatty Acids May Reduce Risk in Obese Postmenopausal Women
March 1, 2016
Research suggests that omega-3 fatty acids may reduce the risk of breast cancer in obese postmenopausal women. Read more...0 -
Faslodex Plus Ibrance Better Than Faslodex Alone for Metastatic, Hormone-Receptor-Positive Disease: Final Analysis of PALOMA-3 Study
March 7, 2016
Ibrance plus Faslodex is better than Faslodex alone for metastatic, hormone-receptor-positive disease that has stopped responding to hormonal therapy. Read more...0 -
About 80% of Women Have PTSD Symptoms After Breast Cancer Diagnosis
March 9, 2016
While a full diagnosis of PTSD after a breast cancer diagnosis was rare, a German study has found that 82.5% of women diagnosed with early-stage disease had symptoms of PTSD between the time they were diagnosed and the start of treatment. Read more...0 -
Research Confirms Women With Oncotype DX Recurrence Score of 11 or Lower Can Skip Chemotherapy
March 14, 2016
The prospective PlanB study has found that women with a Recurrence Score of 11 or lower who skipped chemotherapy based on the Recurrence Score had excellent 5-year survival rates. Read more...0 -
Early MRI Screening Improves Breast Cancer Survival Rates in Women With Childhood Hodgkin Lymphoma
March 15, 2016
Research suggests that starting screening with MRI early can boost breast cancer survival rates in survivors of childhood Hodgkin lymphoma. Read more...0 -
Does Having Preventive Mastectomy Improve Quality of Life?
March 16, 2016
Women who have contralateral prophylactic mastectomy are slightly more satisfied with how their breasts look and feel compared to women who have single mastectomy, but having reconstruction after breast cancer surgery has a bigger effect on satisfaction. Read more...0 -
Adding 3-D Mammography or Ultrasound to Regular Screening Finds More Cancers in Dense Breasts
March 18, 2016
Research shows that adding 3-D mammography or breast ultrasound to regular screening mammograms can detect more cancers in dense breasts. Read more...0 -
Research Suggests Dose-Dense Chemotherapy Improves Survival in Premenopausal Women
March 21, 2016
Premenopausal women diagnosed with early-stage breast cancer that has a high risk of recurrence have better survival if they are treated with a dose-dense chemotherapy regimen. Read more...0 -
Breast Cancer in Men Biologically Different Than Breast Cancer in Women
March 22, 2016
The characteristics of male breast cancer associated with outcomes are different than the characteristics of female breast cancer that are associated with outcomes. Read more...0 -
Response to HER2 Targeted Therapies Seen Just 11 Days After Treatment Starts
March 23, 2016
Some HER2-positive breast cancers may respond very quickly to the combination of Herceptin and Tykerb before surgery -- shrinking dramatically or disappearing entirely after just 11 days of treatment. Read more...0
